Brand Name

Acarbose

View Brand Information
FDA approval date: May 07, 2008
Classification: alpha-Glucosidase Inhibitor
Form: Tablet

What is Acarbose?

Acarbose Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Approved To Treat

Top Global Experts

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

A composite frailty index enables quantification of functional aging and identification of gerotherapeutic drugs in the house cricket.
A composite frailty index enables quantification of functional aging and identification of gerotherapeutic drugs in the house cricket.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Evaluation of the underutilized Malpighia glabra L. fruits as a future functional food: nutritional composition, phenolic profile, biological activities, and synergistic effects with pharmaceutical drugs.
Evaluation of the underutilized Malpighia glabra L. fruits as a future functional food: nutritional composition, phenolic profile, biological activities, and synergistic effects with pharmaceutical drugs.
Journal: Food & function
Published: April 07, 2026
Design, synthesis, and characterization of guanidine derivative with broad-spectrum antimicrobial and antidiabetic inhibitory activities: a comprehensive spectroscopic and computational study.
Design, synthesis, and characterization of guanidine derivative with broad-spectrum antimicrobial and antidiabetic inhibitory activities: a comprehensive spectroscopic and computational study.
Journal: Future microbiology
Published: April 07, 2026
View All Latest Advances